These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29895126)

  • 1. Expression of growth hormone-releasing hormone receptors in apocrine adnexal tumours and apocrine glands of the skin.
    Kővári B; Kocsis L; Varga E; Cserni G
    Pol J Pathol; 2018; 69(1):48-52. PubMed ID: 29895126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation-further evidence of the presence of a GHRH pathway in these tumors.
    Kővári B; Vranic S; Marchio C; Sapino A; Cserni G
    Hum Pathol; 2017 Jun; 64():164-170. PubMed ID: 28438614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
    Ansai S; Koseki S; Hozumi Y; Kondo S
    Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesis.
    Mahalingam M; Srivastava A; Hoang MP
    Am J Dermatopathol; 2010 Dec; 32(8):774-9. PubMed ID: 20700038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
    Mazoujian G
    Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Her-2 expression in cutaneous eccrine and apocrine neoplasms.
    Hiatt KM; Pillow JL; Smoller BR
    Mod Pathol; 2004 Jan; 17(1):28-32. PubMed ID: 14631375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Study of Immunohistochemical Myoepithelial Cell Markers in Cutaneous Benign Cystic Apocrine Lesions.
    Wood A; Houghton SL; Biswas A
    Am J Dermatopathol; 2016 Jul; 38(7):475-83. PubMed ID: 26630681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
    Gatalica Z
    Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histochemical and immunohistochemical markers for human eccrine and apocrine sweat glands: an aid for histopathologic differentiation of sweat gland tumors.
    Saga K
    J Investig Dermatol Symp Proc; 2001 Nov; 6(1):49-53. PubMed ID: 11764285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual apocrine carcinoma with neuroendocrine differentiation: a cutaneous neoplasm may be analogous to neuroendocrine carcinoma with apocrine differentiation of breast.
    Li Y; Chen LL; Li B; Tian XY; Li Z
    Diagn Pathol; 2015 Jun; 10():64. PubMed ID: 26055980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
    Wong TY; Suster S; Cheek RF; Mihm MC
    Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive.
    Kővári B; Rusz O; Schally AV; Kahán Z; Cserni G
    APMIS; 2014 Sep; 122(9):824-31. PubMed ID: 24479854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of GCDFP-15 expression in human fetal and adult normal tissues.
    Viacava P; Naccarato AG; Bevilacqua G
    Virchows Arch; 1998 Mar; 432(3):255-60. PubMed ID: 9532005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous apocrine carcinoma versus metastasis, a plea to the dermatopathology community.
    Fernandez-Flores A
    Am J Dermatopathol; 2010 Dec; 32(8):853-4. PubMed ID: 20431390
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
    Mazoujian G; Margolis R
    Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous apocrine mixed tumor: derived from the apocrine duct of the folliculo-sebaceous-apocrine unit?
    Gianotti R; Coggi A; Alessi E
    Am J Dermatopathol; 1998 Jun; 20(3):323-5. PubMed ID: 9650712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations.
    González-Guerra E; Kutzner H; Rutten A; Requena L
    Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
    Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical demonstration of breast-derived and/or carcinoma-associated glycoproteins in normal skin appendages and their tumors.
    Tsubura A; Senzaki H; Sasaki M; Hilgers J; Morii S
    J Cutan Pathol; 1992 Feb; 19(1):73-9. PubMed ID: 1556271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands.
    Obaidat NA; Alsaad KO; Ghazarian D
    J Clin Pathol; 2007 Feb; 60(2):145-59. PubMed ID: 16882695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.